Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, Ingmar, Hsu, Christine C., Troeger, Juliane S., Huebener, Peter, Mu, Xueru, Dapito, Dianne H., Pradere, Jean-Philippe, Schwabe, Robert F.·2013·Nature Communications

DOI 10.1038/ncomms3823

Cited by (1,001)

Items 201–300 of 1,001

Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury
Shahrouz Ghafoory, Rohan Varshney, Tyler Robison, Karim Kouzbari, Sean Woolington, Brennah Murphy, Lijun Xia, Jasimuddin Ahamed · 2018 · Blood Advances
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Young‐Sun Lee, Ekihiro Seki · 2023 · Cellular and Molecular Gastroenterology and Hepatology
Treatment of liver fibrosis: Past, current, and future
Chunye Zhang, Shuai Liu, Ming Jun Yang · 2023 · World Journal of Hepatology
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
Mohammad Shafi Kuchay, Narendra Singh Choudhary, Bruno Ramos‐Molina · 2025 · American Journal of Physiology-Cell Physiology
Inflammasome: A Double-Edged Sword in Liver Diseases
Jingyun Luan, Dianwen Ju · 2018 · Frontiers in Immunology
Alcohol directly stimulates epigenetic modifications in hepatic stellate cells
Agata Page, Pier P. Paoli, Stephen J. Hill, Rachel Howarth, Raymond P. Wu, Soo-Mi Kweon, Jeremy French, Steve A. White, Hidekazu Tsukamoto, Derek A. Mann et al. · 2014 · Journal of Hepatology
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
Marcher, Ann-Britt, Bendixen, Sofie M., Terkelsen, Mike K., Hohmann, Sonja S., Hansen, Maria H., Larsen, Bjørk D., Mandrup, Susanne, Dimke, Henrik, Detlefsen, Sönke, Ravnskjaer, Kim · 2019 · Scientific Reports
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
Ester Gonzalez‐Sanchez, Javier Vaquero, Maite G. Fernández‐Barrena, Juan José Lasarte, Matias Antonio Avila, Pablo Sarobe, María Reig, Mariona Calvo, Isabel Fabregat · 2021 · Cancers
Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis
Yang Yang, Mayu Sun, Weida Li, Chaobao Liu, Zheshun Jiang, Pengfei Gu, Jingquan Li, Wei Wang, Rongli You, Qian Ba et al. · 2021 · Clinical and Translational Medicine
Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis
Lei, Lin, Bruneau, Alix, El Mourabit, Haquima, Guégan, Justine, Folseraas, Trine, Lemoinne, Sara, Karlsen, Tom Hemming, Hoareau, Bénédicte, Morichon, Romain, Gonzalez‐Sanchez, Ester et al. · 2022 · Hepatology
Exosomes Released by Gastric Cancer Cells Induce Transition of Pericytes Into Cancer-Associated Fibroblasts
Xiaofei Ning, Hongran Zhang, Cong Wang, Xiuqi Song · 2018 · Medical Science Monitor
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee · 2023 · Cellular and Molecular Gastroenterology and Hepatology
Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models
Feng, Dechun, Xiang, Xiaogang, Guan, Yukun, Guillot, Adrien, Lu, Hongkun, Chang, Chingwen, He, Yong, Wang, Hua, Pan, Hongna, Ju, Cynthia et al. · 2023 · Journal of Clinical Investigation
Nadph oxidase 1 in liver macrophages promotes inflammation and tumor development in mice
Liang, Shuang, Ma, Hsiao-Yen, Zhong, Zhenyu, Dhar, Debanjan, Liu, Xiao, Xu, Jun, Koyama, Yukinori, Nishio, Takahiro, Karin, Daniel, Karin, Gabriel et al. · 2019 · Gastroenterology
Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy
Zhang, Ling-Feng, Wang, Xing-Huan, Zhang, Cheng-Lu, Lee, Jaiwoo, Duan, Bo-Wen, Xing, Lei, Li, Ling, Oh, Yu-Kyoung, Jiang, Hu-Lin · 2022 · ACS Nano
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis
Inmaculada López-Sánchez, Ying Dunkel, Yoon‐Seok Roh, Yash Mittal, Samuele De Minicis, Andrea Murányi, Shalini Singh, Kandavel Shanmugam, Nakon Aroonsakool, Fiona Murray et al. · 2014 · Nature Communications
lncRNA GAS5 restrains CCl 4 -induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway
Zhiheng Dong, Sha Li, Xiaohui Wang, Lengge Si, Ruilian Ma, Lidao Bao, Agula Bo · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
Su Kyeom Kim, Yu Heun Kim, Sewon Park, Seung‐Woo Cho · 2021 · Acta Biomaterialia
Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis
Yumei Hao, Kaichao Song, Xiaochuan Tan, Ling Ren, Xiuping Guo, Chuchu Zhou, He Li, Jin Wen, Ya Meng, Mingbao Lin et al. · 2022 · ACS Nano
CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism
Annika Wilhelm, Victoria Aldridge, Debashis Haldar, Amy J. Naylor, Chris J. Weston, Ditte L. Hedegaard, Abhilok Garg, Janine Fear, Gary M. Reynolds, Adam P. Croft et al. · 2015 · Gut
Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences
Swati Joshi‐Barve, Irina Kirpich, Matthew C. Cave, Luis S. Marsano, Craig James McClain · 2015 · Cellular and Molecular Gastroenterology and Hepatology
Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer‐Associated Fibroblasts Formed After Chronic Liver Injuries
Shanshan Wang, Xinyu Thomas Tang, Minghui Lin, Jia Yuan, Yi Jacky Peng, Xiujuan Yin, Guoguo Shang, Gaoxiang Ge, Zhenggang Ren, Bo O. Zhou · 2021 · Hepatology
SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice
Min Li, Wenxuan Hong, Chenzhi Hao, Luyang Li, Dongmei Wu, Aiguo Shen, Jun Lan Lu, Yuan‐Lin Zheng, Ping Li, Yong Xu · 2017 · The FASEB Journal
SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
Xiaolin Zhong, Menghao Huang, Hyeong-Geug Kim, Yang Zhang, Kushan Chowdhury, Wenjie Cai, Romil Saxena, Robert F. Schwabe, Suthat Liangpunsakul, Xiaocheng Charlie Dong · 2020 · Cellular and Molecular Gastroenterology and Hepatology
In vitro reversion of activated primary human hepatic stellate cells
Adil El Taghdouini, Mustapha Najimi, Pau Sancho‐Bru, Etienne Marc Sokal, Leo A. van Grunsven · 2015 · Fibrogenesis & Tissue Repair
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Irina G. Luzina, Nevins W. Todd, Sripriya Sundararajan, Sergei P. Atamas · 2014 · Cytokine
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis
Wu, Xingxin, Wu, Xudong, Ma, Yuxiang, Shao, Fenli, Tan, Yang, Tan, Tao, Gu, Liyun, Zhou, Yang, Sun, Beicheng, Sun, Yang et al. · 2016 · Nature Communications
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis
Yuan Nie, Qi Liu, Wang Zhang, Yipeng Wan, Chenkai Huang, Xuan Zhu · 2021 · Gut Microbes
Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis
Min Tang, Yang Chen, Bingrui Li, Hikaru Sugimoto, Sujuan Yang, Changqing Yang, Valerie S. LeBleu, Kathleen M. McAndrews, Raghu Kalluri · 2021 · The FASEB Journal
Update on the Mechanisms of Liver Regeneration
Morgan Preziosi, Satdarshan P. Monga · 2017 · Seminars in Liver Disease
Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD)
Christina‐Maria Flessa, Ioannis Kyrou, Narjes Nasiri Ansari, Gregory Kaltsas, Eva N. Kassi, Harpal Singh Randeva · 2022 · Journal of Cellular Biochemistry
Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis
Dandan Zheng, Yuchuan Jiang, Chen Qu, Hui Yuan, Kaishun Hu, Lu He, Peng Chen, Jinying Li, Mengxian Tu, Lehang Lin et al. · 2020 · American Journal Of Pathology
MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription
Zilong Li, Baoyu Chen, Wenhui Dong, Ming Kong, Zhiwen Fan, Liming Yu, Dongmei Wu, Jun Lan Lu, Yong Xu · 2019 · Cell Death and Disease
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Raja Gopal Reddy Mooli, Sadeesh Kumar Ramakrishnan · 2022 · Frontiers in Physiology
Deregulated neddylation in liver fibrosis
Imanol Zubiete‐Franco, Pablo Fernández‐Tussy, Lucía Barbier‐Torres, Jorge Simón, David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Virginia Gutiérrez‐de Juan, Sergio López de Davalillo, Antonio Martín Duce, Paula Iruzubieta et al. · 2016 · Hepatology
Liver Tropism in Cancer: The Hepatic Metastatic Niche
Ainhoa Mielgo, Michael C. Schmid · 2019 · Cold Spring Harbor Perspectives in Medicine
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
Müjdat Zeybel, Saimir Luli, Laura Sabater, Timothy Hardy, Fiona Oakley, Jack Leslie, Agata Page, Eva Moran Salvador, Victoria Sharkey, Hidekazu Tsukamoto et al. · 2017 · Molecular Therapy
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Xingpeng Di, Ya Li, Jingwen Wei, Tianyue Li, Banghua Liao · 2024 · Advanced Science
Statins improve NASH via inhibition of RhoA and Ras
Robert Schierwagen, Lara Maybüchen, Kanishka Hittatiya, Sabine Klein, Frank Erhard Uschner, Tárcio Teodoro Braga, Bernardo S. Franklin, Georg Nickenig, Christian P. Strassburg, Jogchum Plat et al. · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
Alessandra Gentilini, Mirella Pastore, Fabio Marra, Chiara Raggi · 2018 · International Journal of Molecular Sciences
Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
Huaxin Chen, Jianye Cai, Jiancheng Wang, Yuan Qiu, Chenhao Jiang, Yi Wang, Yiqin Wang, Chenju Yi, Guo Lv, Lijie Pan et al. · 2020 · Journal of Hepatology
Promising Therapy Candidates for Liver Fibrosis
Ping Wang, Yukinori Koyama, Xiao Liu, Jun Xu, Hsiao‐Yen Ma, Shuang Liang, In H. Kim, David A. Brenner, Tatiana Kisseleva · 2016 · Frontiers in Physiology
MicroRNA‐21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Jorge Matías Caviglia, Jun Yan, Myoung Kuk Jang, Geum‐Youn Gwak, Silvia Affò, Le‐Xing Yu, Peter Olinga, Richard A. Friedman, Xin Chen, Robert F. Schwabe · 2017 · Hepatology
Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Tracey Hurrell, Vlasia Kastrinou‐Lampou, Achilleas Fardellas, Delilah F. G. Hendriks, Åsa Nordling, Inger Johansson, Audrey Baze, Celine Parmentier, Lysiane Richert, Magnus Ingelman‐Sundberg · 2020 · Cells
Genetic tools for identifying and manipulating fibroblasts in the mouse
Jessica M. Swonger, Jocelyn S. Liu, Malina J. Ivey, Michelle D. Tallquist · 2016 · Differentiation
Mesenchymal stromal cells and liver fibrosis: a complicated relationship
Debashis Haldar, Neil Cowan Henderson, Gideon Morris Hirschfield, Philip Noel Newsome · 2016 · The FASEB Journal
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, Leke, Subramanian, Pallavi, Hammerich, Linda · 2023 · Cellular and Molecular Gastroenterology and Hepatology
Serum response factor (SRF) promotes ROS generation and hepatic stellate cell activation by epigenetically stimulating NCF1/2 transcription
Ming Kong, Xuyang Chen, Fangqiao Lv, Haozhen Ren, Zhiwen Fan, Hao Qin, Liming Yu, Xiaolei Shi, Yong Xu · 2019 · Redox Biology
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Nåmdal Vesterhus, Tom H. Karlsen · 2020 · Journal of Gastroenterology
Treg–tissue cell interactions in repair and regeneration
Lucas F. Loffredo, Thomas M. Savage, Olivia Rose Ringham, Nicholas Arpaia · 2024 · The Journal of Experimental Medicine
Initiation of hepatic stellate cell activation extends into chronic liver disease
De Smet, Vincent, Eysackers, Nathalie, Merens, Vincent, Kazemzadeh Dastjerd, Mina, Halder, Georg, Verhulst, Stefaan, Mannaerts, Inge, van Grunsven, Leo A. · 2021 · Cell Death & Disease
Liver ASK1 protects from non‐alcoholic fatty liver disease and fibrosis
Tenagne D. Challa, Stephan Wueest, Fabrizio C. Lucchini, Mara A. Dedual, Salvatore Modica, Marcela Borsigova, Christian Wolfrum, Matthias Blüher, Daniel Konrad · 2019 · EMBO Molecular Medicine
Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis — A review
Yongfang Gong, Yan Yang · 2020 · Life Sciences
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
Jie Zhang, Chaoyu Gu, Qianqian Song, Mengqi Zhu, Yuqing Xu, Mingbing Xiao, Wenjie Zheng · 2020 · Cell & Bioscience
Role of ellagic acid for the prevention and treatment of liver diseases
Venkatasubramanian Aishwarya, Solaipriya Solairaja, Sivaramakrishnan Venkatabalasubramanian · 2020 · Phytotherapy Research
Substrate Stiffness-Driven Membrane Tension Modulates Vesicular Trafficking via Caveolin-1
Dariusz Lachowski, Carlos Matellan, Sahana Gopal, Ernesto Cortés, Benjamin K. Robinson, Alberto Saiani, Aline F. Miller, Molly M. Stevens, Armando E. del Río Hernández · 2022 · ACS Nano
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
You Sun Kim, Edward Hurley, Yoojeong Park, Sungjin Ko · 2023 · Experimental & Molecular Medicine
Tracking Adventitial Fibroblast Contribution to Disease
Jill Toshiko Kuwabara, Michelle D. Tallquist · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
The Importance of Pericytes in Healing: Wounds and other Pathologies
Thomas, Hannah, Cowin, Allison, Mills, Stuart · 2017 · International Journal of Molecular Sciences
Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
Tung‐Hung Su, Jia‐Horng Kao, Chun‐Jen Liu · 2014 · International Journal of Molecular Sciences
Pathophysiology of Sepsis and Genesis of Septic Shock: The Critical Role of Mesenchymal Stem Cells (MSCs)
Matthieu Daniel, Yosra Bedoui, Damien Vagner, Loïc Raffray, Franck Ah-Pine, Bérénice Doray, Philippe Gasque · 2022 · International Journal of Molecular Sciences
The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
Jun Xu, Hsiao‐Yen Ma, Shuang Liang, Mengxi Sun, Gabriel Karin, Yukinori Koyama, Ronglin Hu, Oswald Quehenberger, Nicholas O. Davidson, Edward A. Dennis et al. · 2017 · Hepatology Communications
Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition
Shuai Wang, Xiaolei Shi, Min Feng, Xun Wang, Zhiheng Zhang, Xin Zhao, Bing Han, Hucheng Ma, Bo Dai, Yi-Tao Ding · 2016 · International Immunopharmacology
Antifibrotic Therapies in the Liver
Detlef Schuppan, Wajahat Zafar Mehal · 2015 · Seminars in Liver Disease
Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy
Amin Mahpour, Alan C. Mullen · 2020 · JHEP Reports
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang · 2022 · Biomarker Research
Dynamic cell contacts between periportal mesenchyme and ductal epithelium act as a rheostat for liver cell proliferation
Cordero-Espinoza, Lucía, Dowbaj, Anna M., Kohler, Timo N., Strauss, Bernhard, Sarlidou, Olga, Belenguer, German, Pacini, Clare, Martins, Nuno P., Dobie, Ross, Wilson-Kanamori, John R. et al. · 2021 · Cell Stem Cell
PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target
Shaoping She, Xiaoning Wu, Danfeng Zheng, Xiaolei Pei, Jing Ma, Yameng Sun, Jialing Zhou, Lin Nong, Changyuan Guo, Ping Lv et al. · 2019 · Journal of Hepatology
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Fa-Da Wang, Jing Zhou, En‐Qiang Chen · 2022 · Frontiers in Pharmacology
Involvement of epithelial-mesenchymal transition in liver fibrosis
Ning Li, Kangkang Yu, Qian Li, Guangfeng Shi · 2018 · Saudi Journal of Gastroenterology
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3
Guangyan Wei, Jingsong Cao, Pinzhu Huang, Ping An, Disha Skelton-Badlani, Kahini A. Vaid, Shuangshuang Zhao, David Q.‐H. Wang, Jenny Zhuo, Ling Yin et al. · 2020 · Journal of Hepatology
Metabolic Reprogramming of Liver Fibrosis
Maria Eugenia Delgado, Beatriz Cárdenas, Núria Farran, Mercedes Fernández · 2021 · Cells
Next-Generation Liver Medicine Using Organoid Models
Akbari, Soheil, Arslan, Nur, Senturk, Serif, Erdal, Esra · 2019 · Frontiers in Cell and Developmental Biology
Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis
Guobao Chen, Bin Xia, Qiang Fu, Huang Xiang, Fuping Wang, Zhongmin Chen, Yonggang Lv · 2019 · International Journal of Biological Sciences
Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis
Bai Ruan, Juanli Duan, Hao Xu, Kaishan Tao, Hua Han, Guo‐Rui Dou, Lin Wang · 2021 · Frontiers in Cell and Developmental Biology
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells
Adil El Taghdouini, Anita L. Sørensen, Andrew H. Reiner, Mar Coll, Stefaan Verhulst, Inge Mannaerts, Cristina Ionica Øie, Bård H. Smedsrød, Mustapha Najimi, Etienne Marc Sokal et al. · 2015 · Oncotarget
Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins
Chan Zhou, Samuel R. York, Jennifer Y. Chen, Joshua V. Pondick, Daniel Motola, Raymond T. Chung, Alan C. Mullen · 2016 · Genome Medicine
Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt
Chang Yeob Han, Ja Hyun Koo, Sung Hoon Kim, Sara Gardenghi, Stefano Rivella, Pavel Strnad, Se Jin Hwang, Sang Geon Kim · 2016 · Nature Communications
Primary sclerosing cholangitis
Michael Peter Manns, Annika M Bergquist, Tom H. Karlsen, Cynthia Levy, Andrew Joseph Muir, Cyriel Y. Ponsioen, Michael Trauner, Grace Lai‐Hung Wong, Zobair M. Younossi · 2025 · Nature Reviews Disease Primers
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
Natalie Julia Torok, Jonathan A. Dranoff, Detlef Schuppan, Scott L. Friedman · 2015 · Hepatology
Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity
Gaurav Gupta, Forough Khadem, Jude Ezeh Uzonna · 2018 · Cytokine
The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis
Yanli Li, Xinmei Kang, Zhuowei Zhou, Lijie Pan, Huaxin Chen, Xiaoqi Liang, Jiajie Chu, Shuai Dong, Chang Liu, Shanshan Yu et al. · 2022 · Molecular Therapy
Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer
Ya‐Ling Hsu, Ming‐Shyan Huang, Jen‐Yu Hung, Wei‐An Chang, Ying‐Ming Tsai, Yi‐Chung Pan, Yi-Shiuan Lin, Hung‐Pei Tsai, Po‐Lin Kuo · 2019 · Oncogene
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice
Quanwen Liu, Yan-Min Ying, Jiaxin Zhou, Wenjie Zhang, Zhao-xiao Liu, Bingbing Jia, Hao‐Cheng Gu, Chu-Yu Zhao, Xiao‐Hui Guan, Ke‐Yu Deng et al. · 2022 · Stem Cell Research & Therapy
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
Ren Guo, Xiaohui Jia, Zhen‐Bin Ding, Gang Wang, Mengmeng Jiang, Bing Li, Shanshan Chen, Bingqing Xia, Qing Zhang, Jian Liu et al. · 2022 · Theranostics
A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway
Xianqun Meng, Haixue Kuang, Qiuhong Wang, Hui Zhang, Dan Wang, Ting-Guo Kang · 2023 · International Immunopharmacology
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Xiao‐Feng Lei, Wenguang Fu, Joo‐ri Kim‐Kaneyama, Tomokatsu Omoto, Takuro Miyazaki, Bo Li, Akira Miyazaki · 2015 · Journal of Hepatology
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
Sabine Klein, Johanna Rick, Jennifer Lehmann, Robert Schierwagen, Irela Schierwagen, Len Verbeke, Kanishka Hittatiya, Frank Erhard Uschner, Steffen Manekeller, Christian P. Strassburg et al. · 2015 · Gut
Smooth Muscle α-Actin Deficiency Leads to Decreased Liver Fibrosis via Impaired Cytoskeletal Signaling in Hepatic Stellate Cells
Don C. Rockey, Qing‐Hong Du, Zengdun Shi · 2019 · American Journal Of Pathology
Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation
Annika Wilhelm, Emma L. Shepherd, Aldo Amatucci, Mamoona Munir, Gary M. Reynolds, Elizabeth H. Humphreys, Yazid J. Resheq, David Adams, Stefan G. Hübscher, Linda C. Burkly et al. · 2016 · The Journal of Pathology
It has to be the αv: myofibroblast integrins activate latent TGF-β1
Boris Hinz · 2013 · Nature Medicine
Rationale for the use of statins in liver disease
Robert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, Sabine Klein, Jonel Trebicka · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Reversibility and heritability of liver fibrosis: Implications for research and therapy
Hussein Mousa Atta · 2015 · World Journal of Gastroenterology
Recent understanding of the mechanisms of the biological activities of hesperidin and hesperetin and their therapeutic effects on diseases
Zhongkai Ji, Wei Deng, Dong Chen, Zhidong Liu, Yucheng Shen, Jiuming Dai, Hai Zhou, Miao Zhang, Hucheng Xu, Bin Dai · 2024 · Heliyon
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Stephanie Arndt, Eva Wacker, Christoph Dorn, Andreas Koch, M Saugspier, Wolfgang Erwin Thasler, Arndt Hartmann, Anja‐Katrin Bosserhoff, Claus Hellerbrand · 2014 · Gut
Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells
Sören Siegmund, Monika Schlosser, Frank Alexander Schildberg, Ekihiro Seki, Samuele De Minicis, Hiroshi Uchinami, Christian Kuntzen, Percy Alexander Knolle, Christian P. Strassburg, Robert F. Schwabe · 2016 · PLoS ONE
γδT cells suppress liver fibrosis via strong cytolysis and enhanced NK cell-mediated cytotoxicity against hepatic stellate cells
Liu, Meifang, Hu, Yuan, Yuan, Yi, Tian, Zhigang, Zhang, Cai · 2019 · Frontiers in Immunology
Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling
Xue‐Yin Pan, Hongmei You, Ling Wang, Yihui Bi, Yang Yang, Hongwu Meng, Xiao‐Ming Meng, Taotao Ma, Cheng Huang, Jun Li · 2019 · Theranostics
Primary sclerosing cholangitis
Anahita Rabiee, Marina G. Silveira · 2020 · Translational Gastroenterology and Hepatology
Mouse Models of Liver Fibrosis
Aashreya Ravichandra, Robert F. Schwabe · 2021 · Methods in molecular biology